Literature DB >> 25279548

Baseline drug resistance mutations are detectable in HCV genes NS3 and NS5A but not NS5B in acute and chronic HIV-coinfected patients.

Adele L McCormick1, Luke Moynihan, Malcolm J Macartney, Ana Garcia-Diaz, Colette Smith, Margaret A Johnson, Alison J Rodger, Sanjay Bhagani, Tanzina Haque, Daniel P Webster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25279548     DOI： 10.3851/IMP2871

Source DB:  PubMed          Journal:  Antivir Ther        ISSN： 1359-6535


× No keyword cloud information.
  3 in total

Review 1.  Hepatitis C Virus Treatment: Is It Possible To Cure All Hepatitis C Virus Patients?

Authors:  Andrew J Muir; Susanna Naggie
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-17       Impact factor: 11.382

2.  Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients.

Authors:  Fabián Aldunate; Natalia Echeverría; Daniela Chiodi; Pablo López; Adriana Sánchez-Cicerón; Alvaro Fajardo; Martín Soñora; Juan Cristina; Nelia Hernández; Pilar Moreno
Journal:  Dis Markers       Date:  2018-08-14       Impact factor: 3.434

3.  A Prospective Italian Study on Baseline NS3 and NS5A Resistance to Direct-Acting Antivirals in a Real-World Setting of HIV-1/HCV Coinfected Patients and Association with Treatment Outcome.

Authors:  Sabrina Bagaglio; Hamid Hasson; Luca Peano; Riccardo Vercesi; Emanuela Messina; Andrea Galli; Caterina Uberti Foppa; Giulia Morsica
Journal:  Viruses       Date:  2020-02-28       Impact factor: 5.048
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.